Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.3 EUR | -1.38% | +1.18% | -6.52% |
2023 | GenOway: sharp rise, broker initiates buy recommendation | CF |
2023 | GENOWAY : Euroland initiates buy coverage | CF |
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Genetically Modified Mouse, Rat and Cell Line Models
100.0
%
| 14 | 100.0 % | 17 | 100.0 % | +21.64% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
France
100.0
%
| 14 | 100.0 % | 17 | 100.0 % | +21.64% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Founder | - | 99-02-28 | |
Benjamin Bruneau
DFI | Director of Finance/CFO | - | 15-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 99-02-28 | |
Raffy Kazandjian
BRD | Director/Board Member | - | - |
Patrick Blain
BRD | Director/Board Member | 72 | - |
Director/Board Member | - | - | |
Chief Executive Officer | - | - | |
Andre Tartar
BRD | Director/Board Member | - | - |
Director/Board Member | 59 | - | |
Laurent Fraisse
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 9,046,590 | 6,566,389 ( 72.58 %) | 246,705 ( 2.727 %) | 72.58 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-6.52% | 42.57M | |
+64.10% | 62.59B | |
-1.18% | 41.18B | |
+44.76% | 40.29B | |
-8.29% | 27.9B | |
+13.27% | 26.21B | |
-21.52% | 19.09B | |
+5.51% | 13.08B | |
+25.07% | 12.26B | |
+28.39% | 12.05B |
- Stock Market
- Equities
- ALGEN Stock
- Company genOway